June 10, 2021 -- Veranome Biosystems and Portal Bioscience have entered into a codevelopment agreement to develop products that overcome analytical challenges posed by varying RNA degradation levels found in clinical specimens.
The partnership will combine Portal's probe-specific, ligation-based biochemistry workflow called Proxal chemistry and Veranome's proprietary high-definition imaging instrument and analytics to spatially resolve shorter RNA molecules with the ability to track subtle sequence differences due to splicing or mutation.
In spatial transcriptomics, current assays trade off transcriptome coverage, sensitivity, specificity, and sample throughput. The new collaboration will bring together two complementary workflows that overcome such trade-offs, according to the firms.
Copyright © 2021 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
